Clinical Trial Update: A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial update showing long-term efficacy and safety results for lonapegsomatropin in adults with growth hormone deficiency; the study is completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Skytrofa (lonapegsomatropin)

Snippet

Sponsor: Ascendis Pharma Endocrinology Division A/S | Conditions: Adult Growth Hormone Deficiency, Endocrine System Diseases | Phase 3 | Status: COMPLETED | Results posted: 2026-01-09